{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:07:41Z","timestamp":1748002061262,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10067-022-06252-6","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:04:00Z","timestamp":1657199040000},"page":"2611-2612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Revisiting reactive arthritis during the COVID-19 pandemic"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9651-7295","authenticated-orcid":false,"given":"Dana","family":"Bekaryssova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-6918","authenticated-orcid":false,"given":"Marlen","family":"Yessirkepov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-6018","authenticated-orcid":false,"given":"Armen Yuri","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-311X","authenticated-orcid":false,"given":"Sakir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"6252_CR1","doi-asserted-by":"crossref","unstructured":"Maroua Slouma, Maissa Abbes, Lobna Kharrat, Imen Gharsallah (2022) Post COVID-19 reactive arthritis. Clin Rheumatol Ahead of print","DOI":"10.1007\/s10067-022-06241-9"},{"key":"6252_CR2","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s10067-022-06120-3","volume":"41","author":"D Bekaryssova","year":"2022","unstructured":"Bekaryssova D, Yessirkepov M, Zimba O et al (2022) Reactive arthritis before and after the onset of the COVID-19 pandemic. Clin Rheumatol 41:1641\u20131652. https:\/\/doi.org\/10.1007\/s10067-022-06120-3","journal-title":"Clin Rheumatol"},{"key":"6252_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s0140-6736(87)91910-6","volume":"1","author":"A Keat","year":"1987","unstructured":"Keat A, Thomas B, Dixey J et al (1987) Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1:72\u201374. https:\/\/doi.org\/10.1016\/s0140-6736(87)91910-6","journal-title":"Lancet"},{"key":"6252_CR4","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1186\/ar2748","volume":"11","author":"M Siala","year":"2009","unstructured":"Siala M, Gdoura R, Fourati H et al (2009) Broad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis. Arthritis Res Ther 11:R102. https:\/\/doi.org\/10.1186\/ar2748","journal-title":"Arthritis Res Ther"},{"key":"6252_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11926-021-00982-3","volume":"23","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Padhan P, Misra R, Danda D (2021) Update on post-streptococcal reactive arthritis: narrative review of a forgotten disease. Curr Rheumatol Rep 23:19. https:\/\/doi.org\/10.1007\/s11926-021-00982-3","journal-title":"Curr Rheumatol Rep"},{"key":"6252_CR6","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00296-021-04998-x","volume":"41","author":"BF Kocyigit","year":"2021","unstructured":"Kocyigit BF, Akyol A (2021) Reactive arthritis after COVID-19: a case-based review. Rheumatol Int 41:2031\u20132039. https:\/\/doi.org\/10.1007\/s00296-021-04998-x","journal-title":"Rheumatol Int"},{"key":"6252_CR7","first-page":"2185","volume":"27","author":"J Braun","year":"2000","unstructured":"Braun J, Kingsley G, van der Heijde D, Sieper J (2000) On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3\u20136, 1999. J Rheumatol 27:2185\u20132192","journal-title":"J Rheumatol"},{"key":"6252_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.autrev.2014.01.005","volume":"13","author":"C Selmi","year":"2014","unstructured":"Selmi C, Gershwin ME (2014) Diagnosis and classification of reactive arthritis. Autoimmun Rev 13:546\u2013549. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.005","journal-title":"Autoimmun Rev"},{"key":"6252_CR9","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s10067-017-3720-8","volume":"36","author":"AN Malaviya","year":"2017","unstructured":"Malaviya AN, Agrawal N, Patil NS (2017) Clinical characteristics of peripheral spondyloarthritis without psoriasis, inflammatory enteropathy or preceding infection, from a single rheumatology clinic in northern India. Clin Rheumatol 36:2613\u20132618. https:\/\/doi.org\/10.1007\/s10067-017-3720-8","journal-title":"Clin Rheumatol"},{"key":"6252_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-060173","volume":"12","author":"TA Walker","year":"2022","unstructured":"Walker TA, Grainger R, Quirke T et al (2022) Reactive arthritis incidence in a community cohort following a large waterborne campylobacteriosis outbreak in Havelock North. New Zealand BMJ Open 12:e060173. https:\/\/doi.org\/10.1136\/bmjopen-2021-060173","journal-title":"New Zealand BMJ Open"},{"key":"6252_CR11","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s10067-022-06149-4","volume":"41","author":"LJ Jara","year":"2022","unstructured":"Jara LJ, Vera-Lastra O, Mahroum N et al (2022) Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand? Clin Rheumatol 41:1603\u20131609. https:\/\/doi.org\/10.1007\/s10067-022-06149-4","journal-title":"Clin Rheumatol"},{"issue":"Suppl S1","key":"6252_CR12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/0973-3698.272150","volume":"14","author":"S Ajmani","year":"2019","unstructured":"Ajmani S (2019) Autoimmune\/autoinflammatory syndrome induced by adjuvants: what is it and why the controversy? Indian J Rheumatol 14(Suppl S1):76\u201381","journal-title":"Indian J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06252-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06252-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06252-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T08:49:14Z","timestamp":1700815754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06252-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6252"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06252-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SA reports speaker honorarium from Cipla, Novartis, DrReddy, Pfizer, and Jannsen, outside the submitted work. The other authors have no potential conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}